Reducing tau can prevent abnormal brain activity associated with Alzheimer's disease, autism, and epilepsy.
While the positive impact of breastfeeding on babies is well known, little is known about the positive benefits for the mother. A new study reveals women who breastfed their children performed better on cognitive tests at age 50 than those who fed their children with an alternative method.
While a low-protein diet can accelerate neurodegeneration, consuming Amino LP7, a combination of essential amino acids, could slow the progression or inhibit the development of dementia.
Cold exposure therapies could help alleviate symptoms of multiple sclerosis by depriving the immune system of its energy.
Mirtazapine, an antidepressant commonly prescribed to treat dementia-associated agitation, is no more effective than a placebo and may increase mortality risks, researchers report.
A new study reveals how adipocytes, or fat cells, play a role in cognitive decline and increased neurodegeneration risks. Using genetically modified mouse models, researchers found oxidative stress through exposure to a Western diet increased the production of inflammatory cytokines confined to adipocytes and altered protein markers of memory and cognition in the hippocampus.
Glial cells coordinate immune responses in the gut following infection. Researchers report glial cells could be targets for therapeutics to treat inflammatory bowel disorders.
When dysfunctional, somatostatin interneurons drive brain activity and provoke seizures.
Too much or too little sleep were both linked to increased risk of cognitive decline, researchers report.
Fenofibrate, an FDA-approved drug commonly used to treat high cholesterol, activated support cells around sensory neurons in mouse models of spinal cord injury, helping them regrow twice as fast as a placebo.
Some viral infections could increase intercellular spreading of protein aggregates associated with neurodegenerative disorders, increasing the risk for developing Alzheimer's, Parkinson's, and other neurodegenerative diseases.
A new rodent study uncovers a neural circuit in the brain that appears to govern pain-induced anhedonia. Altering the activity of this circuit restored motivation in pre-clinical models of pain.